BASF Introduces Symbiocell®: A New Solution for Sensitive Skin Approved for Use in China

BASF Introduces Symbiocell®: A New Solution for Sensitive Skin Approved for Use in China

(IN BRIEF) BASF has introduced Symbiocell®, a new cosmetic ingredient derived from Cestrum latifolium leaves, now approved for use in China following a successful regulatory notification. Designed to soothe sensitive skin and reduce excessive skin reactions, Symbiocell® has shown strong clinical results. A face care formulation with 2% Symbiocell® demonstrated significant reductions in skin discomfort and reactivity, outperforming a benchmark product. Feedback from 97% of study participants confirmed enhanced comfort and reduced irritation. Targeting the Asia-Pacific market, Symbiocell® highlights BASF’s focus on innovation, sustainability, and meeting growing consumer demand for effective sensitive skin solutions.

(PRESS RELEASE) LUDWIGSHAFEN, 16-Dec-2024 — /EuropaWire/ — BASF has announced the approval of Symbiocell® as a cosmetic ingredient in China, following a successful new cosmetic ingredient notification. This innovative product, developed by BASF’s Personal Care business, is derived from the leaves of Cestrum latifolium, a plant celebrated in tropical regions for its healing properties. Symbiocell® has been proven through in vitro studies to help maintain healthy basal expression levels of CD86 in skin dendritic cells, offering a soothing effect for sensitive skin and mitigating excessive skin reactions.

Designed to meet the growing demand for sensitive skin care solutions, especially in the Asia-Pacific region, Symbiocell® has shown impressive results in clinical trials. A face care formulation containing 2% Symbiocell® significantly reduced skin discomfort and reactivity. This ingredient aligns with consumer preferences for innovative and effective solutions to common skin concerns.

Clinical Efficacy Demonstrated

BASF conducted a double-blind clinical study with 31 women, comparing a 2% Symbiocell® formulation to a commercially available anti-redness product over three weeks. Results revealed that the side of the face treated with Symbiocell® experienced a 62% reduction in cutaneous discomfort, compared to a 58% reduction for the benchmark product. Additionally, Symbiocell® achieved a significant 20% decrease in the stinging test mean score, while the benchmark product showed only a 14% non-significant reduction.

Volunteer feedback further underscored Symbiocell®’s effectiveness:

• 97% reported their skin felt more comforted and soothed.
• 90% noticed less irritation.
• 87% felt their skin was better prepared to face external aggressors.
• 71% observed improved skin radiance.

A Sustainable and Innovative Approach

Symbiocell® reflects BASF’s commitment to addressing unmet needs in the sensitive skin care market, particularly in regions like Asia-Pacific where demand is rising. Beyond innovation, the product exemplifies BASF’s Care 360° philosophy, which focuses on sustainability, digitalization, and collaborative approaches to creating solutions for a sustainable future.

This milestone reinforces BASF’s position as a leader in cosmetic ingredient innovation, delivering targeted solutions to consumers while emphasizing its dedication to sustainability and market-driven research. Symbiocell® is poised to become a key player in the sensitive skin care category, meeting the needs of consumers seeking comfort, protection, and radiance.

About the Care Chemicals division at BASF

The BASF division Care Chemicals offers a broad range of ingredients for personal care, home care, industrial & institutional cleaning, and technical applications. We are a leading global supplier for the cosmetics industry as well as the detergents and cleaners industry, and support our customers with innovative and sustainable products, solutions and concepts. The division’s high-performance product portfolio includes surfactants, emulsifiers, polymers, emollients, chelating agents, cosmetic active ingredients and UV filters. We have production and development sites in all regions and are expanding our presence in emerging markets. Further information is available online at www.care-chemicals.basf.com.

About BASF

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. Around 112,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio comprises six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of €68.9 billion in 2023. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the United States. Further information at www.basf.com.

Media Contact:

Tarika Wahi Tyagi
Phone: +60 194747533
tarika-wahi.tyagi@basf.com

SOURCE: BASF